Current Approaches in the Treatment of Colorectal Cancer (Predictive and Prognostic Biomarkers) and Non-colorectal Gastrointestinal Cancers

This webcast is jointly provided by A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet.

For more information visit:

This activity is supported in part by independent education grants from Genentech and Lilly USA, LLC.

Release date: December 15, 2014

Valid through: December 15, 2015

Specialty: Hematology/Oncology

Topic: Gastrointestinal Cancers

Target Audience:

This symposium is directed primarily to hematologists/oncologists, radiation oncologists, surgical oncologists, researchers, pharmacists, registered nurses, physician assistants, nurse practitioners and fellows in training interested in new development in colorectal and non-colorectal gastrointestinal cancers.  No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity. 

Program Overview:

This symposium is intended to improve care of patients with colorectal and non-colorectal gastrointestinal cancers by accelerating adoption of new guidelines and evidence-based practice change.  The format will include didactic lectures from known opinion leaders, question and answer sessions, and ample opportunity for participant interaction with faculty.

This program consists of 6 continuing education activites.

Click the links below to review the activity launch pages containing full disclosure information.

Module 1 — Scott Kopetz, MD, PhD and Christopher Lieu, MD — 1.0 AMA PRA Category 1 Credits

Module 2 — Jean-Nicolas Vauthey, MD and Ahmed O. Kaseb, MD — 1.0 AMA PRA Category 1 Credits

Module 3 — Cathy Eng, MD and Michael Overman, MD — 1.25 AMA PRA Category 1 Credits

Module 4 — Nancy You, MD and Christopher H. Crane, MD — 1.25 AMA PRA Category 1 Credits

Module 5 — Linus Ho, MD, PhD and Milind Javle, MD — 1.25 AMA PRA Category 1 Credits

Module 6 — David Hui, MD — 0.5 AMA PRA Category 1 Credits